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Gene editing in human embryonic stem cells (hESCs) has been significantly enhanced
by the discovery and development of CRISPR Cas9, a programmable nuclease system
that can introduce targeted double-stranded breaks. The system relies on the optimal
selection of a sgRNA sequence with low off-targets and high efficiency. We designed
an improved monomeric red fluorescent protein reporter, GEmCherry2, for assessing
CRISPR Cas9 activity and for optimizing sgRNA. By incorporating an out-of-frame
sequence to the N-terminal of the red fluorescent protein mCherry, we created a
visual tool for assessing the indel frequency after cutting with CRISPR Cas9. When a
sgRNA-Cas9 construct is co-transfected with a corresponding GEmCherry2 construct,
single nucleotide indels can move the GEmCherry2 sequence back in-frame and allow
quantification and comparison of the efficiency of different sgRNA target sites by
measuring red fluorescence. With this GEmCherry2 assay, we compared four target
sites in the safe harbor AAVS1 locus and found significant differences in target site
activity. We verified the activity using TIDE, which ranked our target sites in a similar order
as the GEmCherry2 system. We also identified an AAV short inverted terminal repeat
sequence within the Cas9 construct that, upon removal significantly improved transient
transfection and expression in hESCs. Moreover, using GEmCherry2, we designed a
sgRNA to target SORCS2 in hESCs and successfully introduced indels into the coding
sequence of SORCS2.
Keywords: CRISPR/Cas9, pluripotent stem cells, INDEL mutation, homologous recombination, human embryonic
stem cells, gene targeting techniques, safe harbor loci
INTRODUCTION
Human embryonic stem cells (hESCs) and human induced pluripotent stem cells (hiPSCs)
are an invaluable cell source for recapitulating and studying early developmental or disease
processes. Furthermore, refined differentiation methods capable of generating patient-specific
cell derivatives have the potential to improve cell replacement therapies for numerous diseases,
including neurodegenerative diseases such as Parkinson’s disease. In addition to hiPSC technology,
recent advancements in gene editing techniques have aided these efforts by increasing the ease at
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which genome editing can be performed, for applications
including correction or deletion of genes or creation of reporter
cell lines for the study of developmental processes.
During the last decade, several gene-editing techniques have
been developed, such as Zinc finger nucleases (ZFN) and the
transcription activator-like effector nucleases (TALENS) which
feature a customizable DNA binding domain, allowing its protein
sequence to be modified to target specific genomic sequences.
The requirements to custom-modify the protein sequence for
each target site limits its broad application. Alternatively, the
clustered regularly interspersed palindromic repeats (CRISPR)
associated nuclease Cas9 system can bemodified to target specific
DNA sites; this system is simple to customize as it uses the
same protein sequence in each case. The type II CRISPR Cas9
system requires only the modification of a synthetic single
guide RNA (sgRNA), which can be programmed to identify
a 20 base-pair sequence that is followed by a protospacer-
adjacent motif (PAM) sequence -NGG. This sgRNAmodification
is therefore inexpensive and straightforward in comparison to
ZFN and TALENS. Furthermore, this system results in a site-
specific double-stranded break (DSB) between the 17th and 18th
bases in the target sequence, unlike the indiscriminate cutting
employed by the Fokl endonuclease used in ZNF and TALENS.
The CRISPR system is therefore easily programmed and results
in a site-specific DSB, making it a valuable tool for iPSC genome
engineering.
Previous reports have shown that the guide RNA architecture
and targeting site can both influence Cas9 activity (Sander and
Joung, 2014). Several methods for assessing Cas9 activity has
been reported, including the use of a surrogate dual fluorescent
reporter system, SURVEYOR, RFLP, TIDE, whole genome, or
exome sequencing (Kim et al., 2011; Ran et al., 2013b; Brinkman
et al., 2014; Cho et al., 2014; Kuhar et al., 2016; Zhou et al., 2016).
Although all these systems can determine Cas9 activity, some also
capable of assessing off-targets, they are somewhat hampered by
either low sensitivity, labor-intensive procedures, or use multiple
fluorescent proteins that prevent the assessment of Cas9 co-
transfection. Here we describe the development of a modified
monomeric red fluorescent protein (RFP) for measuring Cas9
activity, which serves as a rapid tool for evaluating sites with high
Cas9 activity. We demonstrate that this technique can be rapidly
employed to identify highly efficient sites within the AAVS1
safe harbor locus or in a protein coding sequence. Furthermore,
for efficient plasmid transfection of Cas9 sgRNA constructs
into hPSCs we increased transient expression by removal of an
Adeno-associated virus (AAV) inverted terminal repeat (ITR)
sequence that inhibited transgene expression.
METHODS
hESC Culture
The H9 (WA-09, WiCell) hESC line was cultured as previously
described (Denham and Dottori, 2011). Briefly, cells were
maintained on a feeder layer of mitomycin-C treated human
foreskin fibroblasts in KSR media (DMEM/F-12, 0.1mM β-
mercaptoethanol, 1% nonessential amino acids, 2mM glutamine,
0.5% pen/strep, 20% knockout serum replacement) containing
15 ng/mL Activin A and 15 ng/mL FGF2. Before Nucleofection
or infection, H9 was transferred to a feeder-free system on
Vitronectin coated plates in E8 media (StemCell Technologies).
All cells were grown at 37◦C and 5% CO2.
HEK293T Culture
HEK293T cells were cultured in FDMEM (DMEM 4.5%glucose,
10% FBS, 0.5% pen/strep, 1% Glutamax, 1% non-essential amino
acids, 1% sodium pyruvate; ThermoFisher Scientific) in T75
(SARSTEDT) flasks and split by trypsination before reaching
confluency. Cells were grown at 37◦C, 5% CO2.
Lipofectamine Transfection of HEK293T
Cells
HEK293T cells were transfected using Lipofectamine 2000
according to manufacturer’s protocol. On the day before
transfection, the cells were plated in multi-well plates (6-well or
12-well (SARSTEDT)) to reach ∼85% confluency at the time of
transfection. The cells were transfected with up to 2 µg of total
plasmid DNA per well for 6-well plates and up to 1 µg of total
plasmid DNA per well for 12-well plates.
Nucleofection of hESCs
H9 cells from Vitronectin plates were dissociated to single cells
using Accutase (ThermoFisher Scientific) after being incubated
with 10µM ROCK inhibitor (Y27632) for at least 1 h. After
diluting the Accutase with E8 media, the cells were counted and
200,000 cells per reaction were spun down (300 xG, 5min) and
resuspended in premixed Nucleofection solution, P3 (Lonza).
Twenty micro-liters of cell suspension was added to a maximum
of 2 µg of total DNA (no more than 2 µL) and transferred
to a Nucleofection chamber (16-well strip). The H9 cells were
transfected using parameter CM 130, P3 solution, and plated
out on Vitronectin coated plates (35mm, Nunc) in E8 media
supplemented with 10µM ROCK inhibitor. Media was changed
to regular E8 media after 1–2 days.
Fluorescence Activated Cell Sorting (FACS)
analysis
HEK293T cells were co-transfected with GEmCherry and
corresponding CRISPR-Cas9 vectors. The cells were imaged
under a fluorescent microscope at 48 h post-transfection. After
imaging, the cells were trypsinised (0.25% trypsin-EDTA) to a
single cell suspension, washed in phosphate buffered saline (PBS)
and fixed in 4% paraformaldehyde (PFA) for 20min at 4◦C. The
fixed cells were washed and put through a 40µm cell strainer
before being sorted against GFP andmCherry on an LSR Fortessa
cell analyser.
Polymerase Chain Reactions (PCRs)
PCR of genomic AAVS1 regions was carried out with OneTaq hot
start DNA polymerase (NEB) as described by the manufacturer,
with an initial denaturation step of 4min and an annealing
temperature of 63◦C. Primers are listed in (Figure S1).
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Cloning
GEmCherry constructs were produced using the pmCerulean3-
N1 (Addgene: 54730) backbone and cloning in the mCherry
gene by PCR amplification from E[beta]C (Addgene: 24312) and
N-terminal changes added by primer extension, producing
the following vectors: pGEmCherry1, pGEmCherry2,
pGEmCherry3, pGEmCherry4. The CBh promoter in
pSpCas9(BB)-2A-GFP (PX458) (Addgene: 48138) was swapped
for the CAG promoter, which was amplified by PCR from
pPB-CAG.OSKM-puDtk (Yusa et al., 2009) producing the final
vector pCAG-SpCas9-2A-GFP. The GEmCherry vector was cut
with XbaI and BamHI (NEB) to allow insertion of target sites.
The oligos (target sequences in Figure S1) were annealed before
ligating them into the backbone finally producing GEmCherry2-
C2, GEmCherry2-C3, GEmCherry2-C4, GEmCherry2-T2,
GEmCherry2-TS1+3, and GEmCherry2-TS2. The Cas9 vector
was constructed according to protocol (Ran et al., 2013b),
producing pSpCas9-2A-GFP-sgC2, pSpCas9-2A-GFP-sgC3,
pSpCas9-2A-GFP-sgC4, pSpCas9-2A-GFP-sgT2, pSpCas9-
2A-GFP-sgSORCS2-G1, pSpCas9-2A-GFP-sgSORCS2-G2,
pSpCas9-2A-GFP-sgSORCS2-G3, and LentiCRISPRv2-
sgSORCS2-G2. Cloning was carried out using electrocompetent
Stbl3 or Top10 E. coli cells. The AAV ITR fragment was removed
from pCAG-SpCas9-2A-GFP by double digestion with NotI
and SbfI to remove a 145 bp fragment including the ITR
element. After removing the ITR element, two ssDNA oligos
were synthesized (Sigma) and annealed to produce a fragment
containing a BamHI site with two sticky ends compatible
with the NotI and SbfI and ligated in with T4 DNA ligase
kit (ThermoFisher EL0016) according to the manufacturer
instructions. The following vector without an ITR was produced:
pCAG-SpCas9-2A-GFP-noITR. All plasmids have been made
publicly available through the Addgene non-profit plasmid
repository.
Lentiviral Production and Infection
Lentivirus was produced similarly to what was previously
described (Denham et al., 2010). HEK293T cells were transfected
by Lipofectamine 2000 with plasmids LentiCRISPRv2_SORCS2-
G2, envelope plasmid pMD2.G, and packaging vector psPAX2
to generate lentiviral particles. The viral supernatant was
harvested at 48 and 72 h post-transfection and concentrated
by ultracentrifugation. Single cells of H9 on Vitronectin
coated 35mm dishes (6,000 cells per dish) were infected with
concentrated lentivirus. At 48 h post-infection, Puromycin was
added for 5 days (0.125µg/mL Puromycin; ThermoFisher).
Immunostaining
Immunocytochemistry was performed on cells grown on
coverslips (VWR, Ø: 13mm) and fixed in 4% PFA. Samples were
blocked for 1 h at room temperature with 5% donkey serum
in PBS-T (PBS with 0.25% triton-X). Primary antibodies were
applied in blocking solution at room temperature overnight
(GFP, rabbit, abcam: ab290, 1:1000; POU5F1,mouse IgG2b, Santa
Cruz: sc-5279, 1:100) and washed off, 3x 10min, with PBS-T and
samples blocked for 10min before applying secondary antibody
in block solution for 1 h at room temperature (AlexaFluor 488
donkey anti-rabbit, 1:1000; AlexaFluor 568 donkey anti-mouse
IgG (H + L), 1:1000). The secondary antibodies were washed
off 3x 10min in PBS-T before applying DAPI (1:1000 in PBS)
for 10min at room temperature. Coverslips were washed 3x
5min with PBS before mounted on microscope slides with PVA
DABCO (Sigma Aldrich).
Spectral Imaging
Emission wavelength and intensity of GEmCherry1, 2, and
3 was measured using λ-scan with ZEISS Confocal LSM800
microscope. Intensity was normalized within each sample and
then plotted against emission wavelength in PRISM GraphPad 6.
Sequencing
Sanger sequencing was carried out by EurofinsGenomics in
ValueRead or Mix2Seq tubes. Sequencing samples were prepared
according to manufacturers guidelines but with 300 ng of
PCR product per sample. Sequencing primers are described in
(Figure S1).
Statistical Analysis
FACS analysis was performed on 50,000 events per replicate
using FlowJo software. Statistical analysis, consisting of one-
way ANOVAs, adjusting for multiple comparisons with Tukey’s
correction, and unpaired two-tailed t-test was done using PRISM
GraphPad 6. Mean gray-scale value was found using FIJI ImageJ
on images taken with Zeiss Apotome microscope (no apotome
function). Quantification of GFP/POU5F1 positive cells was done
by measuring pixel area using FIJI ImageJ on images from
Olympus IX53 microscope.
TIDE Analysis
TIDE analysis was performed on the AAVS1 locus (PCR primers
listed in Figure S1) from cultures sorted for GFP positive cells
using the tide.nki.nl tool (version 0.1; Brinkman et al., 2014)
run in R. The alignment window was set manually from where
the Sanger sequencing chromatogram looked reliable and until
10 bp before the break site (corresponding R function modified
to fix alignment window; code is available via osf.io/97ef4).
The decomposition window was set at 400 bp, starting 42 bp
downstream of the break site. The indel size range was set at 38
bp and the p-value significance cut-off at 0.001.
The reported efficiency of sgRNAs is likely an underestimate
due to primer design, which did not allow for comparative
analysis of an indel size range larger than 38 bp.
RESULTS
Development of a Monomeric RFP
Reporter for Measuring CRISPR Activity
In order to obtain the highest targeting efficiency using
CRISPR/Cas9 we first sought to develop a rapid system for
evaluating sgRNA efficiency by developing a single fluorescent
system to assess Cas9 activity that could be used in conjunction
with existing CRISPR Cas9 GFP plasmids, such as the pCas9-
GFP. This approach would allow for FACS based or visual
assessment of double positive GFP/RFP fluorescence, resulting
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in a precise assessment of sgRNA efficiency. To achieve this, we
incorporated an out-of-frame genomic target region into the N-
terminal site of the mCherry fluorescent protein. Standard N-
terminal fusion constructs maintain the original methionine start
site and append N-terminal tags to the protein in-frame with an
additional methionine. However, to facilitate short out-of-frame
N-terminal sequences and prevent alternate start site initiation
we removed the native methionine start site. This strategy was
designed to prevent translation from the longest open reading
frame when N-terminal fragments are out-of-frame. The append
N-terminal fragment would correspond to the genomic fragment
in this plasmid, which we named GEmCherry1 (Figures 1A,D).
Following transfection with GEmCherry1, and despite
the methionine start site modifications, high fluorescence
was observed when an out-of-frame sequence was inserted
(Figure 1E). We reasoned that a downstream methionine site
might be responsible for alternative initiation of translation.
We identified that positions 14 and 21 contained methionine
sites and modified these to leucine, an alternate amino
acid with similar structure, generating the GEmCherry2
vector and additionally the 3rd ATG site at position 27
generating GEmCherry3 (Figure 1A). In addition, we generated
a GEmCherry4 vector where CTG for leucine was mutated to
TTA at positions 14 and 21, as we hypothesized that CTG could
function as a weak alternative translation start site (Schwab
et al., 2004). GEmCherry4 did not show significant differences
in either in-frame or out-of-frame fluorescence compared to
GEmCherry2 (Figure 1F). Transfection with in-frame sequences
revealed that all modifications maintained red fluorescence
(Figures 1B,C). Moreover, when an out-of-frame fragment was
inserted, background fluorescence was significantly perturbed in
GEmcherry2, GEmCherry3, and GEmCherry4 (Figure 1E). Only
the intensity, and not the emission wavelength, changed upon
mutating the GEmCherry sequence (Figure 1C).
Evaluation of all four constructs on background out-of-frame
fluorescence and in-frame brightness revealed that GEmCherry2
was the superior choice with the lowest background fluorescence
(67.89% lower than GEmCherry1, p < 0.0001) and maintained
the brightest in-frame fluorescence (39.04% of GEmCherry1
fluorescence intensity, p < 0.0001; Figure 1F).
Identification of an Optimal CRISPR AAVS1
Site
After successfully engineering a single fluorescent protein,
GEmCherry2, which can facilitate an out-of-frame N-
terminal fusion for measuring Cas9 activity, we tested whether
GEmCherry2 could be used to measure Cas9 activity for a given
genomic sequence. We chose the AAVS1 locus (PPP1R12C)
as a site, since it has been targeted successfully before with
ZFN, TALENS, and CRISPR/Cas9 (Hockemeyer et al., 2009;
Dekelver et al., 2010; Mali et al., 2013). Furthermore, this
site is a known safe harbor locus, which makes it suitable for
future transgene targeting. Firstly, we identified sequences
with the lowest off-targets by CRISPOR (Haeussler et al.,
2016). From this, we selected three sites designated C2, C3,
and C4 (Figure S1) for assessing sgRNA Cas9 activity. These
three sites were compared to the T2 site commonly used
by others (Hockemeyer et al., 2009). Recognition sequences
were cloned into GEmCherry2 and sgRNA sequences into
the Cas9-GFP vector. Co-transfection and FACS analysis
revealed that significant variation in Cas9 activity was observed
between the genomic sequences (Figures 2A,B), confirming that
sgRNA architecture and recognition site sequence contributes
toward Cas9 activity. Based on GEmCherry2 fluorescence, we
determined that sgRNA C4 had the highest efficiency, at 5.504
times that of C3 (p < 0.0001). C2 and T2 were also significantly
greater than C3 [C2 (4.803), p < 0.0001; T2 (4.493), p < 0.0001].
No significant difference between C4, C2, and T2 were observed.
Based on CRISPOR, C4 contained only two in-exon off-targets,
both with four mismatches, whereas the T2 site contained 21
in-exon off-targets each with four mismatches and one in-exon
off-target with a three base-pair mismatch (Figure S2). Overall,
the off-target assessment and cutting efficiency of C4 makes it a
superior choice when targeting the AAVS1 locus with high Cas9
activity and the lowest potential off-targets.
Comparative Efficiency Assessment of
GEmCherry2 and TIDE Assay
Having determined that GEmCherry2 can be used to assess
sgRNAs and Cas9 activity, we further sought to validate
this technique and compare the efficiency determined by
GEmCherry2 to Cas9 activity in the genomic locus. Epigenetic
modifications can influence the ability of Cas9 to access the
genomic DNA and may affect its activity in a genomic context.
Therefore, we performed the TIDE assay (Brinkman et al., 2014)
on the same CRISPR AAVS1 target sites and calculated the indel
frequency as a measure of Cas9 activity. The TIDE assay revealed
that, similar to the GEmCherry2 assay, Cas9 activity varied
between these sites (Figures 3A,B). Interestingly, the ranking
of the various sites was in a similar order to that identified
by GEmCherry2, with both methods identifying the AAVS1-C4
sgRNA as the most efficient (Figures 2B, 3A,B). This data reveals
that GEmCherry2 can be effectively and rapidly used as a method
for determining Cas9 activity.
Gene Editing in Human Embryonic Stem
Cells
Finally, we used GEmCherry2 to design a sgRNA to knockout
a protein-coding gene in hESCs. We chose to target SORCS2,
a proneurotrophin receptor expressed in neurons and we
designed three sgRNA against regions in the first coding exon
(Glerup et al., 2014). Evaluating these with GEmCherry2, we
identified sgRNA SORCS2-G2 as the most efficient sgRNA
(Figures 4A,B). To introduce Cas9 and the sgRNA into
hESCs, we tested the plasmid pSpCas9(BB)-2A-GFP (Ran
et al., 2013b). After transfection, we found that transient
expression from the Cas9 constructs [pSpCas9(BB)-2A-GFP
(PX458); Addgene: 48138] was almost absent in comparison
to other GFP reporter plasmids of similar size (data not
shown). We therefore modified the plasmid and exchanged
the Cbh promoter for a stronger CAG promoter, resulting
in the plasmid pCAG-SpCas9-2A-GFP, which only resulted in
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FIGURE 1 | Development of monomeric RFP reporter for measuring CRISPR Cas9 activity. (A) Protein sequence of mCherry, GEmCherry1 with N-terminal
modification to allow insertion of 23 bp target site, GEmCherry2 with two ATG→CTG mutations to decrease background fluorescence, GEmCherry3 with three
ATG→CTG mutations and GEmCherry4 with two ATG→TTA mutations. (B) Images of HEK293T cells transfected with in-frame GEmCherry constructs (GEmCherry in
red; DAPI in blue; scale bar = 100µm). (C) λ-scan showing that only the intensity but not the emission spectra changes upon mutating the GEmCherry sequence. (D)
By insertion of 23 bp target sequence, the reading frame will be pushed to induce a premature stop-codon abolishing fluorescence. Cas9 targeting and induction of
indels will move the sequence back in-frame and again allow for the expression of red fluorescent protein. (E) HEK293T cells transfected with out-of-frame
GEmCherry constructs (GEmCherry in red; DAPI in blue; scale bar = 100µm). (F) Quantification of fluorescence intensity of in-frame (solid color) and out-of-frame
(striped) constructs. In-frame intensity of GEmCherry1 was significantly higher than GEmCherry2, 3, and 4 (p < 0.0001, n = 3) but so was the out-of-frame
background fluorescence (p < 0.0001, n = 3). The in-frame intensity between GEmCherry3 and GEmCherry2, and 4 was also significantly different (p = 0.0068 and
p = 0.0008, n = 3) but the out-of-frame background fluorescence was not. For GEmCherry2, 3, and 4 the out-of-frame background fluorescence was not significantly
different than the no-plasmid control, based on the pixel density, although low background fluorescence was visibly observable in both GEmCherry 2, 3, and 4.
One-way ANOVA with Tukey’s test were performed. Results are presented as mean with SD.
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FIGURE 2 | Identification of optimal CRISPR Cas9 AAVS1 site. (A) HEK293T cells were co-transfected with CRISPR Cas9-GFP constructs with four different sgRNAs
targeting the AAVS1 locus and target site specific out-of-frame GEmCherry2 constructs (GEmCherry in red; GFP in green; scale bar = 100µm). The shift to in-frame
expression of RFP was visualized and the number of co-transfected, GFP+ and RFP+, cells were analyzed by FACS. (B) The fluorescent intensity, and thereby
sgRNA efficiency, was estimated as high intensity RFP++ cells/GFP+ cells (percentages of RFP++ cells shown in FACS plots in A). Cas9 activity at target site C2,
C4, and T2 was, based on fluorescent intensity, estimated to be significantly higher (p < 0.0001, n = 3) than C3. We saw no significant difference in fluorescence
intensity between C2, C4, and T2, although a trend was seen toward C4 being slightly more efficient (arbitrary unit). One-way ANOVA with Tukey’s test was
performed. Results are presented as mean with SD.
marginal improvements in GFP expression (Figure 4C). After
in silico analysis of the Cas9 plasmid sequence we identified an
ITR sequence from an AAV within the construct as the only
distinct difference between the plasmids. Subsequent removal
of this AAV sequence was shown to significantly restore
transfection efficiency and expression in hESCs (p = 0.0446;
Figures 4C,D), resulting in the final plasmid pCAG-SpCas9-2A-
GFP-noITR. In parallel to transient transfection, we produced
lentiviral particles containing Cas9 and sgRNA SORCS2-G2.
This method proved the most rapid and efficient targeting
method in hESCs. From the lentiviral-infected hESCs, 10
clones were expanded and three analyzed for indels in
SORCS2 exon-1. Results showed that all three clones were
successfully targeted and contained indels in SORCS2 and,
interestingly, clone 9 displayed a heterozygous sequence
(Figure 4E).
DISCUSSION
Gene editing in human pluripotent stem cells is challenging
in comparison to mouse pluripotent stem cells which can
be clonally expanded in the presence of LIF, facilitating the
survival and selection of targeted clones. Homology-directed
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FIGURE 3 | AAVS1 sgRNA efficiency assessment by TIDE. (A) Representative indel spectrum analysis of AAVS1 locus from HEK293T cells transfected with CRISPR
Cas9-GFP sgRNA C2, C3, C4, or T2 (*p < 0.001; statistical analysis by TIDE version 0.1). The TIDE analysis was performed in three biological replicates. The average
overall efficiency and the average R2 value for C2, C3, C4, and T2 is specified on each indel spectrum. (B) Overall CRISPR-Cas9 efficiency of C2, C3, C4, and T2
constructs as assessed by TIDE. C4 was significantly different from C2 and C3 (*p < 0.05, One-Way ANOVA with Tukey’s test, n = 3, mean with SD). Cells were
sorted for GFP prior to genomic DNA extraction.
repair methods have been improved significantly by the discovery
of Cas9 and its development as a programmable nuclease system
for targeted DSBs (Mali et al., 2013; Ran et al., 2013a). Despite
these advancements, practical challenges of efficiently producing
targeted clones remain. This study describes an optimized
method for designing sgRNA sequences and an improved sgRNA
delivery vector. Herein, we describe the development of a rapid
assay system, GEmCherry2, which uses a single fluorescent
reporter for assessing CRISPR Cas9 activity at sgRNA target
sites. When compared with the TIDE assay, the GEmCherry2
assay showed a similar ranking of sequences (Brinkman et al.,
2014). Additionally, and similar to the dual surrogate reporter
system, the GEmCherry2 system can be used to assess ZFN,
TALENS, DNA system efficiencies, or dual-nickase variants
(Kim et al., 2011). Furthermore, an advantage of our reporter
system over the dual fluorescent system is that it can be
used in conjunction with a Cas9-GFP plasmid to evaluate
Cas9 activity and overcome transfection efficiency discrepancies
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FIGURE 4 | Gene editing in human embryonic stem cells. (A) Based on GEmCherry2 fluorescence we estimated the efficiency of three different sgRNAs (G1, G2, and
G3) targeting exon1 of the SORCS2 gene. HEK293T cells were co-transfected with CRISPR Cas9-GFP and GEmCherry2 constructs and the Cas9 cutting efficiency
was estimated based on high-intensity in-frame fluorescence (GEmCherry in red; GFP in green; scale bar = 100µm). (B) The fluorescence intensity (measured as
pixel density) was quantified as GEmCherry against GFP fluorescence and normalized against the out-of-frame background fluorescence. The fluorescence intensity
was not significantly different between the G1, G2, and G3 sgRNA, although a trend was seen toward G2 generating more high-intensity RFP++ cells (One-Way
ANOVA with Tukey’s test, n = 3, mean with SD). (C) Images of hESCs stained against POU5F1, GFP, and DAPI (scale bar = 100µm) after transfection with either
pCAG-SpCas9-2A-GFP (top) or pCAG-SpCas9-2A-GFP-noITR (bottom). (D) Quantification of transfection efficiency and GFP expression before and after deletion of
the AAV ITR from the pCAG-SpCas9-2A-GFP vector (*p = 0.0446; nITR = 6, nnoITR = 5). Unpaired two-tailed t-test was performed. Results are presented as mean
with SD. (E) Sanger sequencing of the genomic region of H9 control and three H9-SORCS2 knock-out cell lines (clone 8, 9, and 10). The expected cut site of sgRNA
SORCS2-G2 is marked in yellow.
more precisely. Using this system as a primary screen, we
were able to identify a novel AAVS1 Cas9 active site with a
low number of off-target sites and high Cas9 activity and we
designed an efficient sgRNA for SORCS2. We attempted gene-
targeting in hESCs and found that the majority of available
CRISPR Cas9 plasmids contain an AAV ITR sequence in their
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backbone that reduces transfection efficiency and transient
expression. This silencing may be occurring in hESCs through
a similar mechanism to what has been reported in other cell
types, by which the ITR regions are rapidly identified and
methylated by the host cell (Chanda et al., 2017). After removal
of these sequences, a significant improvement in transfection
efficiency and transient expression was obtained. Furthermore,
as an alternative and more efficient method for Cas9-mediated
knock-out of SORCS2, we used lentiviruses, which are highly
efficient at infecting hESCs (Gropp et al., 2003). With this
rapid delivery system, we produced 10 clones and selected
three for subsequent screening of indels in the SORCS2 coding
sequence. This approach proved to be highly efficient as all
three clones showed indels in the region around the target
site.
In addition to efficient sgRNA design, several methods exist
for delivering Cas9 and sgRNA. The choice of delivery method
will depend on the specific cell type and the application of
either gene disruption or homologous recombination, which
requires a repair template. Some of these methods include
delivery of cell-penetrating Cas9 and guide RNA, capped
RNA or integrase-deficient lentiviral vectors (Kim et al., 2014;
Ramakrishna et al., 2014; Ortinski et al., 2017). In our
approach, we used lentiviruses to infect hESCs. However,
combining this with integrase-deficient or self-inactivating
systems, such as Self-Limiting Cas9 circuit for Enhanced
Safety and specificity (SLiCES) would be more desirable as
they prevent the on-going expression of Cas9 (Petris et al.,
2017).
Additional applications for GEmCherry2 also include
assessing sgRNA activity against close matching off-target
sequences in the genome or in patient lines with heterozygous
single-nucleotide mutations. Sequences with multiple
mismatches may be less problematic as modified version of
Cas9 have recently been described, such as an enhanced Cas9
and a high-fidelity Cas9 that both have significantly reduced
off-targets (Kleinstiver et al., 2016; Slaymaker et al., 2016).
Nevertheless, the PAM-site restriction of spCas9 has also
brought about the development and identification of alternate
CRISPR endonucleases, which will all interact with off-targets
differently (Hou et al., 2013; Kleinstiver et al., 2015; Zetsche et al.,
2015; Hu et al., 2018).
In conclusion, we have developed a single fluorescent reporter
system for evaluating sgRNA sequences and optimized a plasmid
system for transfection into hPSCs. By combining the highest
efficiency of genomic sgRNA sequence with improved plasmid
transfection efficiency, a reduced number of cells would be
required when performing homologous directed repair in hPSCs,
which currently requires large-scale production to identify
correctly targeted clones.
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Figure S1 | Primers and oligos used for targeting the AAVS1 locus (PPP1R12C)
and validating CRISPR Cas9 activity at the target sites. AAVS1 target sites C2,
C3, C4, and T2, including PAM-sequence, used for designing sgRNA and
GEmCherry target sequences. Regional primers to PCR the AAVS1 locus from
genomic DNA from cells transfected with Cas9 constructs. Sequencing primers
used for TIDE analysis, designed for sequencing to start close to the Cas9 cut site
(65–120 bp upstream of cut site). SORCS2 target sites G1, G2, and G3, including
PAM-sequence (all in exon1). Regional primers to PCR the SORCS2 G2 target site
from genomic DNA from knock-out H9 cell lines. The G2 fwd primer was also
used for Sanger sequencing.
Figure S2 | Evaluation of PPP1R12C sgRNA design and off-target effects using
http://crispor.tefor.net/ with input PPP1R12C sequence: Homo sapiens (hg19),
chr19:55626073-55628048, reverse genomic strand. The table shows the target
sequence (guide sequence + PAM), specificity score, predicted efficiency,
out-of-frame score, number of off-targets for up to four mismatches flanked by
motif –NGG, –NAG, or –NGA (total/in-exon), and the number of mismatches and
affected gene.
REFERENCES
Brinkman, E. K., Chen, T., Amendola, M., and Van Steensel, B. (2014). Easy
quantitative assessment of genome editing by sequence trace decomposition.
Nucleic Acids Res. 42:e168. doi: 10.1093/nar/gku936
Chanda, D., Hensel, J. A., Higgs, J. T., Grover, R., Kaza, N., and Ponnazhagan,
S. (2017). Effects of cellular methylation on transgene expression
and site-specific integration of adeno-associated virus. Genes. 8:E232.
doi: 10.3390/genes8090232
Cho, S. W., Kim, S., Kim, Y., Kweon, J., Kim, H. S., Bae, S., et al.
(2014). Analysis of off-target effects of CRISPR/Cas-derived RNA-guided
endonucleases and nickases. Genome Res. 24, 132–141. doi: 10.1101/gr.1623
39.113
Dekelver, R. C., Choi, V. M., and Moehle, E. A. (2010). Functional genomics,
proteomics , and regulatory DNA analysis in isogenic settings using
zinc finger nuclease-driven transgenesis into a safe harbor locus in
the human genome. Genome Res. 20, 1133–1142. doi: 10.1101/gr.106
773.110
Frontiers in Cell and Developmental Biology | www.frontiersin.org 9 May 2018 | Volume 6 | Article 54
Højland Knudsen et al. Fluorescent Assessment of CRISPR Activity
Denham,M., and Dottori, M. (2011). Neural differentiation of induced pluripotent
stem cells.Methods Mol. Biol. 793, 99–110. doi: 10.1007/978-1-61779-328-8_7
Denham,M., Thompson, L. H., Leung, J., Pébay, A., Björklund, A., and Dottori, M.
(2010). Gli1 is an inducing factor in generating floor plate progenitor cells from
human embryonic stem cells. Stem Cells 28, 1805–1815. doi: 10.1002/stem.510
Glerup, S., Olsen, D., Vaegter, C. B., Gustafsen, C., Sjoegaard, S. S., Hermey,
G., et al. (2014). SorCS2 regulates dopaminergic wiring and is processed into
an apoptotic two-chain receptor in peripheral glia. Neuron 82, 1074–1087.
doi: 10.1016/j.neuron.2014.04.022
Gropp, M., Itsykson, P., Singer, O., Ben-Hur, T., Reinhartz, E., Galun, E., et al.
(2003). Stable genetic modification of human embryonic stem cells by lentiviral
vectors.Mol. Ther. 7, 281–287. doi: 10.1016/S1525-0016(02)00047-3
Haeussler, M., Schönig, K., Eckert, H., Eschstruth, A., Mianné, J., Renaud, J.-B.,
et al. (2016). Evaluation of off-target and on-target scoring algorithms and
integration into the guide RNA selection tool CRISPOR. Genome Biol. 17:148.
doi: 10.1186/s13059-016-1012-2
Hockemeyer, D., Soldner, F., Beard, C., Gao, Q., Mitalipova, M., DeKelver, R.
C., et al. (2009). Efficient targeting of expressed and silent genes in human
ESCs and iPSCs using zinc-finger nucleases. Nat. Biotechnol. 27, 851–857.
doi: 10.1038/nbt.1562
Hou, Z., Zhang, Y., Propson, N. E., Howden, S. E., Chu, L.-F., Sontheimer, E. J.,
et al. (2013). Efficient genome engineering in human pluripotent stem cells
using Cas9 from Neisseria meningitidis. Proc. Natl. Acad. Sci. U.S.A. 110,
15644–15649. doi: 10.1073/pnas.1313587110
Hu, J. H., Miller, S. M., Geurts, M. H., Tang, W., Chen, L., Sun, N., et al. (2018).
Evolved Cas9 variants with broad PAM compatibility and high DNA specificity.
Nature 556, 57–63. doi: 10.1038/nature26155
Kim, H., Um, E., Cho, S.-R., Jung, C., Kim, H., and Kim, J.-S. (2011). Surrogate
reporters for enrichment of cells with nuclease-induced mutations. Nat.
Methods 8, 941–943. doi: 10.1038/nmeth.1733
Kim, S., Kim, D., Cho, S. W., Kim, J., and Kim, J.-S. (2014). Highly efficient
RNA-guided genome editing in human cells via delivery of purified Cas9
ribonucleoproteins. Genome Res. 24, 1012–1019. doi: 10.1101/gr.171322.113
Kleinstiver, B. P., Pattanayak, V., Prew, M. S., Tsai, S. Q., Nguyen, N. T., Zheng,
Z., et al. (2016). High-fidelity CRISPR–Cas9 nucleases with no detectable
genome-wide off-target effects. Nature 529, 490–495. doi: 10.1038/nature16526
Kleinstiver, B. P., Prew, M. S., Tsai, S. Q., Topkar, V. V., Nguyen, N. T., Zheng, Z.,
et al. (2015). Engineered CRISPR-Cas9 nucleases with altered PAM specificities.
Nature 523, 481–485. doi: 10.1038/nature14592
Kuhar, R., Gwiazda, K. S., Humbert, O., Mandt, T., Pangallo, J., Brault, M., et al.
(2016). Novel fluorescent genome editing reporters for monitoring DNA repair
pathway utilization at endonuclease-induced breaks. Nucleic Acids Res. 42:e4.
doi: 10.1093/nar/gkt872
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., et al. (2013).
RNA-guided human genome engineering via Cas9. Science 339, 823–826.
doi: 10.1126/science.1232033
Ortinski, P. I., O’Donovan, B., Dong, X., and Kantor, B. (2017). Integrase-
deficient lentiviral vector as an all-in-one platform for highly efficient
CRISPR/Cas9-mediated gene editing. Mol. Ther. Methods Clin. Dev. 5,
153–164. doi: 10.1016/j.omtm.2017.04.002
Petris, G., Casini, A., Montagna, C., Lorenzin, F., Prandi, D., Romanel, A., et al.
(2017). Hit and go CAS9 delivered through a lentiviral based self-limiting
circuit. Nat. Commun. 8, 1–9. doi: 10.1038/ncomms15334
Ramakrishna, S., Kwaku Dad, A. B., Beloor, J., Gopalappa, R., Lee, S. K.,
and Kim, H. (2014). Gene disruption by cell-penetrating peptide-mediated
delivery of Cas9 protein and guide RNA. Genome Res. 24, 1020–1027.
doi: 10.1101/gr.171264.113
Ran, F. A., Hsu, P. D., Lin, C. Y., Gootenberg, J. S., Konermann, S., Trevino, A.
E., et al. (2013a). Double nicking by RNA-guided CRISPR cas9 for enhanced
genome editing specificity. Cell 154, 1380–1389. doi: 10.1016/j.cell.2013.08.021
Ran, F. A., Hsu, P. D., Wright, J., Agarwala, V., Scott, D. A., and Zhang, F.
(2013b). Genome engineering using the CRISPR-Cas9 system. Nat. Protoc. 8,
2281–2308. doi: 10.1038/nprot.2013.143
Sander, J. D., and Joung, J. K. (2014). CRISPR-Cas systems for editing, regulating
and targeting genomes. Nat. Biotechnol. 32, 347–355. doi: 10.1038/nbt.2842
Schwab, S. R., Shugart, J. A., Horng, T., Malarkannan, S., and Shastri, N. (2004).
Unanticipated antigens: translation initiation at CUG with leucine. PLoS Biol.
2:e366. doi: 10.1371/journal.pbio.0020366
Slaymaker, I. M., Gao, L., Zetsche, B., Scott, D. A., Yan,W. X., and Zhang, F. (2016).
Rationally engineered Cas9 nucleases with improved specificity. Science 351,
84–88. doi: 10.1126/science.aad5227
Yusa, K., Rad, R., Takeda, J., and Bradley, A. (2009). Generation of transgene-
free induced pluripotent mouse stem cells by the piggyBac transposon. Nat.
Methods 6, 363–369. doi: 10.1038/nmeth.1323
Zetsche, B., Gootenberg, J. S., Abudayyeh, O. O., Slaymaker, I. M., Makarova, K. S.,
Essletzbichler, P., et al. (2015). Cpf1 is a single RNA-guided endonuclease of a
class 2 CRISPR-cas system. Cell 163, 759–771. doi: 10.1016/j.cell.2015.09.038
Zhou, Y., Liu, Y., Hussmann, D., Brøgger, P., Al-Saaidi, R. A., Tan, S., et al. (2016).
Enhanced genome editing in mammalian cells with a modified dual-fluorescent
surrogate system. Cell. Mol. Life Sci. 73, 1–21. doi: 10.1007/s00018-015-
2128-3
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
The reviewer GP and handling Editor declared their shared affiliation.
Copyright © 2018 Højland Knudsen, Ásgrímsdóttir, Rahimi, Gill, Frandsen,
Hvolbøl Buchholdt, Chen, Kjems, Febbraro and Denham. This is an open-access
article distributed under the terms of the Creative Commons Attribution License (CC
BY). The use, distribution or reproduction in other forums is permitted, provided
the original author(s) and the copyright owner are credited and that the original
publication in this journal is cited, in accordance with accepted academic practice.
No use, distribution or reproduction is permitted which does not comply with these
terms.
Frontiers in Cell and Developmental Biology | www.frontiersin.org 10 May 2018 | Volume 6 | Article 54
